#scleroderma 검색 결과

Biologic Therapy for Refractory Juvenile Scleroderma” by Dr. Munirah Al Marri was accepted at #ACR25 – Chicago 🇺🇸! The world’s main rheumatology conference, covering both adult & pediatric advances. A proud step forward in improving care for young patients. #Scleroderma

Drasiri1000's tweet image. Biologic Therapy for Refractory Juvenile Scleroderma” by Dr. Munirah Al Marri
was accepted at #ACR25 – Chicago 🇺🇸!

The world’s main rheumatology conference, covering both adult & pediatric advances.
A proud step forward in improving care for young patients. 

#Scleroderma…

🧵1/ 👁 Ever wanted to see autoimmune Microvascular dysfunction in action? Nailfold Videocapillaroscopy (NVC) gives us a live look into systemic vascular health. A powerful, non-invasive window for early diagnosis in CTDs. Let’s walk through what it reveals in #Scleroderma.…

IlliasulK's tweet image. 🧵1/
👁 Ever wanted to see autoimmune Microvascular dysfunction in action?

Nailfold Videocapillaroscopy (NVC) gives us a live look into systemic vascular health. A powerful, non-invasive window for early diagnosis in CTDs.

Let’s walk through what it reveals in #Scleroderma.…

While NSIP & UIP are common patterns on HRCT, COP, LIP & DIP can occur in #Scleroderma-ILD. Neither NSIP nor UIP are independent predators of survival. @HanaRheum #EULAR2025

SindhuJohnson5's tweet image. While NSIP & UIP are common patterns on HRCT, COP, LIP & DIP can occur in #Scleroderma-ILD. Neither NSIP nor UIP are independent predators of survival. @HanaRheum #EULAR2025

#Scleroderma specific autoantibodies in predicting prognosis/survival ➡️ almost all #ANA positive 📈 Best survival in anticentromere group 📉 Diffuse subtype carries a worse prognosis especially Anti-Scl70, anti-RNA polymerase III & If 🫁 ILD present [AL Herrick]

LastManStand85's tweet image. #Scleroderma specific autoantibodies in predicting prognosis/survival 

➡️ almost all #ANA positive

📈 Best survival in anticentromere group
 
📉 Diffuse subtype carries a worse prognosis especially Anti-Scl70, anti-RNA polymerase III & If 🫁 ILD present 

[AL Herrick]

Hey everyone! Today is #WorldSclerodermaDay I’m raising awareness about this debilitating disease! I’m in my 4th year. Don’t give up hope! We will find a cure. I’m happy to be thriving. Thanks for the love! ❤️🙏🏼#scleroderma

ClaireDeVille3's tweet image. Hey everyone! Today is #WorldSclerodermaDay I’m raising awareness about this debilitating disease! I’m in my 4th year. Don’t give up hope! We will find a cure. I’m happy to be thriving. Thanks for the love! ❤️🙏🏼#scleroderma

2 years ago,I was invited onto @BBCSheffield Paulette's show to talk about my #scleroderma I've kindly been invited back on to talk about allsorts this Wednesday morning! Wish me luck !!

sclerodermasara's tweet image. 2 years ago,I was invited onto @BBCSheffield Paulette's show to talk about my #scleroderma 
I've kindly been invited back on to talk about allsorts this Wednesday morning! Wish me luck !!

#scleroderma 1. why is SSc- a 'fibrotic disease' treated with immunosuppressive? 2. Why dont every patient with early SSc respond to immunosuppressive? the lessons lie in understanding the underlying mechanisms of early SSc and molecular heterogeneity. @IRACON24Blr

sclerodermaUM's tweet image. #scleroderma 
1. why is SSc- a 'fibrotic disease' treated with immunosuppressive?
2. Why dont every patient with early SSc respond to immunosuppressive? 
the lessons lie in understanding the underlying mechanisms of early SSc and molecular heterogeneity.  @IRACON24Blr
sclerodermaUM's tweet image. #scleroderma 
1. why is SSc- a 'fibrotic disease' treated with immunosuppressive?
2. Why dont every patient with early SSc respond to immunosuppressive? 
the lessons lie in understanding the underlying mechanisms of early SSc and molecular heterogeneity.  @IRACON24Blr

Excited to present WIN #scleroderma #eular2025. This slide highlights the opportunities in drug development in SSc. Come and join on Saturday 6/14 at 9 AM CET.

sclerodermaUM's tweet image. Excited to present  WIN  #scleroderma #eular2025. This slide highlights the opportunities in drug development in  SSc. Come and join on Saturday 6/14 at 9 AM CET.

Excited to present data from RESET-SSc in #scleroderma #eular2025. CAR-T was well tolerated with beneficial effects on skin/ FVC. Exciting data on U-M IIS with LN bx showing complete depletion of B cells at 3 weeks and NFC showing normalization of capillary density and size

sclerodermaUM's tweet image. Excited to present data from RESET-SSc in #scleroderma #eular2025. CAR-T was well tolerated with beneficial effects on skin/ FVC. Exciting data on U-M IIS with LN bx showing complete depletion of B cells at 3 weeks and NFC showing normalization of capillary density and size
sclerodermaUM's tweet image. Excited to present data from RESET-SSc in #scleroderma #eular2025. CAR-T was well tolerated with beneficial effects on skin/ FVC. Exciting data on U-M IIS with LN bx showing complete depletion of B cells at 3 weeks and NFC showing normalization of capillary density and size
sclerodermaUM's tweet image. Excited to present data from RESET-SSc in #scleroderma #eular2025. CAR-T was well tolerated with beneficial effects on skin/ FVC. Exciting data on U-M IIS with LN bx showing complete depletion of B cells at 3 weeks and NFC showing normalization of capillary density and size
sclerodermaUM's tweet image. Excited to present data from RESET-SSc in #scleroderma #eular2025. CAR-T was well tolerated with beneficial effects on skin/ FVC. Exciting data on U-M IIS with LN bx showing complete depletion of B cells at 3 weeks and NFC showing normalization of capillary density and size

🆕CD19 CAR T Cell treatment -A potentially promising future treatment in #SLE #scleroderma #myositis -Needs close collaboration with haematology Great explanation by @chriswincup #ACR24 #Lupus #SystemicSclerosis #IIM

gurdeep_dulay's tweet image. 🆕CD19 CAR T Cell treatment

-A potentially promising future treatment in #SLE #scleroderma #myositis 

-Needs close collaboration with haematology

Great explanation by @chriswincup #ACR24  #Lupus #SystemicSclerosis #IIM

Systemic Sclerosis–Associated ILD Watch Alicia Hinze, MD, share personalized strategies for managing Systemic Sclerosis–Associated ILD. Sponsored By: Boehringer Ingelheim buff.ly/w9qmEr7 #ILD #Scleroderma

RheumNow's tweet image. Systemic Sclerosis–Associated ILD

Watch Alicia Hinze, MD, share personalized strategies for managing Systemic Sclerosis–Associated ILD. Sponsored By: Boehringer Ingelheim 

buff.ly/w9qmEr7 

#ILD #Scleroderma

Standardized note templates, pre-filled test requisitions and referral forms significantly increase uptake of #Scleroderma care quality indicators. #EULAR2025 @AboabatAos @Samar_Aboul @UofTRheum @SchroederInst @UHN_Research

SindhuJohnson5's tweet image. Standardized note templates, pre-filled test requisitions and referral forms significantly increase uptake of #Scleroderma care quality indicators. #EULAR2025 @AboabatAos @Samar_Aboul @UofTRheum @SchroederInst @UHN_Research

Delighted to present the @bmsnews data on #scleroderma #eular2025. Breakfree-1 data showing CAR-T is well tolerated with beneficial effects on skin and FVC and composite endpoint, the revised CRISS.

sclerodermaUM's tweet image. Delighted to present the @bmsnews data on #scleroderma #eular2025. Breakfree-1 data showing CAR-T is well tolerated with beneficial effects on skin and FVC and composite endpoint, the revised CRISS.
sclerodermaUM's tweet image. Delighted to present the @bmsnews data on #scleroderma #eular2025. Breakfree-1 data showing CAR-T is well tolerated with beneficial effects on skin and FVC and composite endpoint, the revised CRISS.
sclerodermaUM's tweet image. Delighted to present the @bmsnews data on #scleroderma #eular2025. Breakfree-1 data showing CAR-T is well tolerated with beneficial effects on skin and FVC and composite endpoint, the revised CRISS.

Join expert rheumatologists from @NorthwesternMed for the Scleroderma Educational Event on October 24. This event will explore the latest developments in #scleroderma research and management from a multidisciplinary perspective. Learn more and register now:…


Did you know around 20% of people with #scleroderma also have #lupus? 💜 These crossover conditions show why awareness and early detection matter. This #NationalAwarenessMonth, let’s shine a light on this condition and those living with it.

scleroderma_vic's tweet image. Did you know around 20% of people with #scleroderma also have #lupus? 💜

These crossover conditions show why awareness and early detection matter.

This #NationalAwarenessMonth, let’s shine a light on this condition and those living with it.

Join expert rheumatologists from @NorthwesternMed for the Scleroderma Educational Event on October 24. This event will explore the latest developments in #scleroderma research and management from a multidisciplinary perspective. Learn more and register now:…


📑Our latest #scleroderma literature highlights, featuring research by Chung et al., are now live on the #SclerodermaForum. 👉Access these comprehensive slide decks for the latest insights in #scleroderma treatment: ow.ly/ISHJ50WYOch

ScleroForum's tweet image. 📑Our latest #scleroderma literature highlights, featuring research by Chung et al., are now live on the #SclerodermaForum. 

👉Access these comprehensive slide decks for the latest insights in #scleroderma treatment: ow.ly/ISHJ50WYOch

👩‍⚕️ Tight, mask-like face? Think Scleroderma (Systemic Sclerosis) — not Sjögren’s or Lupus. Early recognition of skin tightening & Raynaud’s = better outcomes. #Rheumatology #MedTwitter #Scleroderma #GPs #RheumRounds @DrAkhilX @IhabFathiSulima @Janetbirdope

Rheumat_Aravind's tweet image. 👩‍⚕️ Tight, mask-like face?
Think Scleroderma (Systemic Sclerosis) — not Sjögren’s or Lupus.
Early recognition of skin tightening & Raynaud’s = better outcomes.

#Rheumatology #MedTwitter #Scleroderma #GPs #RheumRounds @DrAkhilX @IhabFathiSulima @Janetbirdope

This clinical sign is mostly associated with which of the following condition? A) Sjögren syndrome B) Scleroderma C) Dermatomyositis D) Lupus

TrackYourHeart's tweet image. This clinical sign is mostly associated with which of the following condition?
A) Sjögren syndrome
B) Scleroderma
C) Dermatomyositis
D) Lupus


Biologic Therapy for Refractory Juvenile Scleroderma” by Dr. Munirah Al Marri was accepted at #ACR25 – Chicago 🇺🇸! The world’s main rheumatology conference, covering both adult & pediatric advances. A proud step forward in improving care for young patients. #Scleroderma

Drasiri1000's tweet image. Biologic Therapy for Refractory Juvenile Scleroderma” by Dr. Munirah Al Marri
was accepted at #ACR25 – Chicago 🇺🇸!

The world’s main rheumatology conference, covering both adult & pediatric advances.
A proud step forward in improving care for young patients. 

#Scleroderma…

Congrats to Dr. Ruhani Desai, Assassi, and the scleroderma team for publishing the largest correlative study between skin ultrasound and histology in systemic sclerosis. #scleroderma pubmed.ncbi.nlm.nih.gov/41098036/


Join expert rheumatologists from @NorthwesternMed for the Scleroderma Educational Event on October 24. This event will explore the latest developments in #scleroderma research and management from a multidisciplinary perspective. Learn more and register now:…


Got my results from my yearly lung function test and I've improved in almost every category! 🙌🏾 #Scleroderma


Join expert rheumatologists from @NorthwesternMed for the Scleroderma Educational Event on October 24. This event will explore the latest developments in #scleroderma research and management from a multidisciplinary perspective. Learn more and register now:…


Our new paper on Scleroderma Assessment Questionnaire (SAQ) and its relation to clinical characteristics & disease severity in systemic sclerosis is now published! 🧾 Free access until Dec 5, 2025 👉 authors.elsevier.com/a/1ly76_PFRfX6… #Rheumatology #SystemicSclerosis #Scleroderma #Research


If you've read my blog 1 Day 1 Week you know my mom has #Scleroderma & related Interstitial Lung Disease. Another beautiful mom -- this one of @IAMQUEENLATIFAH also suffered from these & is the inspiration behind this wonderful, important video. youtu.be/flHQSBc6KQ4

1day1weekblog's tweet image. If you've read my blog 1 Day 1 Week you know my mom has #Scleroderma & related Interstitial Lung Disease. Another beautiful mom -- this one of @IAMQUEENLATIFAH also suffered from these & is the inspiration behind this wonderful, important video.
youtu.be/flHQSBc6KQ4

🧠 #RheumPearl: Nailfold capillaroscopy distinguishes primary vs secondary #Raynauds & stages #Scleroderma. ✅ Normal (Primary Raynaud): 7–10 loops/mm, smooth convex apex, 20 µm diameter Early: giant >50 µm 🩸Active: hemorrhage + ↓density ⚙️ Late: <3/mm, avascular #NowYouKnowIt


Join expert rheumatologists from @NorthwesternMed for the Scleroderma Educational Event on October 24. This event will explore the latest developments in #scleroderma research and management from a multidisciplinary perspective. Learn more and register now:…


🔎 Discover the newest findings in #scleroderma in our latest literature highlights. Enhance your clinical knowledge with free access on the #SclerodermaForum: ow.ly/1URA50WYO7G

ScleroForum's tweet image. 🔎 Discover the newest findings in #scleroderma in our latest literature highlights. 

Enhance your clinical knowledge with free access on the #SclerodermaForum: ow.ly/1URA50WYO7G

What is the #sign? #ClinicalPearl hint Pt has #scleroderma #SSc

Janetbirdope's tweet image. What is the #sign?

#ClinicalPearl

hint Pt has #scleroderma #SSc
Janetbirdope's tweet image. What is the #sign?

#ClinicalPearl

hint Pt has #scleroderma #SSc

Biologic Therapy for Refractory Juvenile Scleroderma” by Dr. Munirah Al Marri was accepted at #ACR25 – Chicago 🇺🇸! The world’s main rheumatology conference, covering both adult & pediatric advances. A proud step forward in improving care for young patients. #Scleroderma

Drasiri1000's tweet image. Biologic Therapy for Refractory Juvenile Scleroderma” by Dr. Munirah Al Marri
was accepted at #ACR25 – Chicago 🇺🇸!

The world’s main rheumatology conference, covering both adult &amp;amp; pediatric advances.
A proud step forward in improving care for young patients. 

#Scleroderma…

#Scleroderma organ specific associated antibodies. #systemicsclerosis & Antibodies associated w/overlap SSc Extracted from Textbook Scleroderma From Pathogenesis to Comprehensive management 2024 #Rheumatology #MedTwitter 👇

LastManStand85's tweet image. #Scleroderma organ specific associated antibodies. #systemicsclerosis &amp;amp; Antibodies associated w/overlap SSc 

Extracted from Textbook Scleroderma From Pathogenesis to Comprehensive management 2024 

#Rheumatology #MedTwitter 

👇
LastManStand85's tweet image. #Scleroderma organ specific associated antibodies. #systemicsclerosis &amp;amp; Antibodies associated w/overlap SSc 

Extracted from Textbook Scleroderma From Pathogenesis to Comprehensive management 2024 

#Rheumatology #MedTwitter 

👇

🧵1/ 👁 Ever wanted to see autoimmune Microvascular dysfunction in action? Nailfold Videocapillaroscopy (NVC) gives us a live look into systemic vascular health. A powerful, non-invasive window for early diagnosis in CTDs. Let’s walk through what it reveals in #Scleroderma.…

IlliasulK's tweet image. 🧵1/
👁 Ever wanted to see autoimmune Microvascular dysfunction in action?

Nailfold Videocapillaroscopy (NVC) gives us a live look into systemic vascular health. A powerful, non-invasive window for early diagnosis in CTDs.

Let’s walk through what it reveals in #Scleroderma.…

#Scleroderma specific autoantibodies in predicting prognosis/survival ➡️ almost all #ANA positive 📈 Best survival in anticentromere group 📉 Diffuse subtype carries a worse prognosis especially Anti-Scl70, anti-RNA polymerase III & If 🫁 ILD present [AL Herrick]

LastManStand85's tweet image. #Scleroderma specific autoantibodies in predicting prognosis/survival 

➡️ almost all #ANA positive

📈 Best survival in anticentromere group
 
📉 Diffuse subtype carries a worse prognosis especially Anti-Scl70, anti-RNA polymerase III &amp;amp; If 🫁 ILD present 

[AL Herrick]

#Scleroderma mimics From Textbook Scleroderma From Pathogenesis to Comprehensive management. Chapter 11 (Hummers et Tyndall) 2024 👇 #Rheumatology #MedTwitter

LastManStand85's tweet image. #Scleroderma mimics 
From Textbook Scleroderma From Pathogenesis to Comprehensive management. Chapter 11 (Hummers et Tyndall) 2024 👇 
#Rheumatology #MedTwitter

While NSIP & UIP are common patterns on HRCT, COP, LIP & DIP can occur in #Scleroderma-ILD. Neither NSIP nor UIP are independent predators of survival. @HanaRheum #EULAR2025

SindhuJohnson5's tweet image. While NSIP &amp;amp; UIP are common patterns on HRCT, COP, LIP &amp;amp; DIP can occur in #Scleroderma-ILD. Neither NSIP nor UIP are independent predators of survival. @HanaRheum #EULAR2025

Great @SmidtHeart #research seminar by X. Mike Jones. Lead #ncRNA compound TY1 reverses the key manifestations of #scleroderma in two complementary mouse models! It even works orally. Next goal: first-in-human studies in #systemicsclerosis patients! @CedarsSinaiMed

MarbanLab's tweet image. Great @SmidtHeart #research seminar by X. Mike Jones. Lead #ncRNA compound TY1 reverses the key manifestations of #scleroderma in two complementary mouse models! It even works orally. Next goal: first-in-human studies in #systemicsclerosis patients!
@CedarsSinaiMed

Dr. Aos Aboabat, #Scleroderma Clinical Research Fellow @SchroederInst, supervised by Dr. @SindhuJohnson5, presented his research at the Rheumatology Ogryzlo Research Day @UofT and will be graduating this year!  #WorldSclerodermaDay

SchroederInst's tweet image. Dr. Aos Aboabat, #Scleroderma Clinical Research Fellow @SchroederInst, supervised by Dr. @SindhuJohnson5, presented his research at the Rheumatology Ogryzlo Research Day @UofT and will be graduating this year!  #WorldSclerodermaDay
SchroederInst's tweet image. Dr. Aos Aboabat, #Scleroderma Clinical Research Fellow @SchroederInst, supervised by Dr. @SindhuJohnson5, presented his research at the Rheumatology Ogryzlo Research Day @UofT and will be graduating this year!  #WorldSclerodermaDay

Bang-up @MarbanLab mtg presentation by @nih_nhlbi #T32 fellow @XMichaelJonesMD gives new hope for #scleroderma. In two #mouse models and human #SSc #macrophages (🙏@fboinMD), #ncRNA drug TY1 attenuates #DNAdamage and reverses disease. 👍. Thanks Mike for your great work!…

MarbanLab's tweet image. Bang-up @MarbanLab mtg presentation by @nih_nhlbi #T32 fellow @XMichaelJonesMD gives new hope for #scleroderma. In two #mouse models and human #SSc #macrophages (🙏@fboinMD), #ncRNA drug TY1 attenuates #DNAdamage and reverses disease. 👍. Thanks Mike for your great work!…
MarbanLab's tweet image. Bang-up @MarbanLab mtg presentation by @nih_nhlbi #T32 fellow @XMichaelJonesMD gives new hope for #scleroderma. In two #mouse models and human #SSc #macrophages (🙏@fboinMD), #ncRNA drug TY1 attenuates #DNAdamage and reverses disease. 👍. Thanks Mike for your great work!…
MarbanLab's tweet image. Bang-up @MarbanLab mtg presentation by @nih_nhlbi #T32 fellow @XMichaelJonesMD gives new hope for #scleroderma. In two #mouse models and human #SSc #macrophages (🙏@fboinMD), #ncRNA drug TY1 attenuates #DNAdamage and reverses disease. 👍. Thanks Mike for your great work!…
MarbanLab's tweet image. Bang-up @MarbanLab mtg presentation by @nih_nhlbi #T32 fellow @XMichaelJonesMD gives new hope for #scleroderma. In two #mouse models and human #SSc #macrophages (🙏@fboinMD), #ncRNA drug TY1 attenuates #DNAdamage and reverses disease. 👍. Thanks Mike for your great work!…

Prophylactic ACEi in #Scleroderma? No benefit, worse outcomes in renal crisis! #Rheumatology #MedTwitter #BSR25

LastManStand85's tweet image. Prophylactic ACEi in #Scleroderma?

No benefit, worse outcomes in renal crisis!

#Rheumatology #MedTwitter #BSR25

First steps towards developing an approvable PRO for early #scleroderma. #ACR24. COAST questionnaire. being tested in the @srfcure CONQUEST platform trial

sclerodermaUM's tweet image. First steps towards developing an approvable PRO for early #scleroderma. #ACR24. COAST questionnaire. being tested in the @srfcure CONQUEST platform trial

On #WorldSclerodermaDay let's spread awareness about #Scleroderma! Early diagnosis focuses on detecting symptomatic patients as early as possibile, it is the key to make a significant difference in treatment outcomes!

EmanuelaPraino's tweet image. On #WorldSclerodermaDay let&apos;s spread awareness about #Scleroderma! Early diagnosis focuses on detecting symptomatic patients as early as possibile, it is the key to make a significant difference in treatment outcomes!

🆕CD19 CAR T Cell treatment -A potentially promising future treatment in #SLE #scleroderma #myositis -Needs close collaboration with haematology Great explanation by @chriswincup #ACR24 #Lupus #SystemicSclerosis #IIM

gurdeep_dulay's tweet image. 🆕CD19 CAR T Cell treatment

-A potentially promising future treatment in #SLE #scleroderma #myositis 

-Needs close collaboration with haematology

Great explanation by @chriswincup #ACR24  #Lupus #SystemicSclerosis #IIM

Hey everyone! Today is #WorldSclerodermaDay I’m raising awareness about this debilitating disease! I’m in my 4th year. Don’t give up hope! We will find a cure. I’m happy to be thriving. Thanks for the love! ❤️🙏🏼#scleroderma

ClaireDeVille3's tweet image. Hey everyone! Today is #WorldSclerodermaDay I’m raising awareness about this debilitating disease! I’m in my 4th year. Don’t give up hope! We will find a cure. I’m happy to be thriving. Thanks for the love! ❤️🙏🏼#scleroderma

Loading...

Something went wrong.


Something went wrong.


United States Trends